FDA-Inspected Site

Enterra Medical, Inc.

1 FDA inspection is on record for Enterra Medical, Inc. in Minneapolis, United States.

483· Form 483 issued

Minneapolis, United States · Last updated August 15, 2026

Overview

  • 1 FDA inspection is on record.
  • 1 inspection produced a Form 483.
  • The most recent recorded inspection date is 2026-05-04.

At a glance

Inspections

1

Form 483s

1

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
27 Apr 2026 – 4 May 2026Medical Devices & Rad Health483View 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

4 May 2026
ISO 13485:2016 Clause 4.1.2

Risk-based approach not applied to QMS processes

Cited by Tyler R Courtney

4 May 2026
ISO 13485:2016 Clause 7.1

Product realization risk management processes not documented

Cited by Tyler R Courtney

4 May 2026
ISO 13485:2016 Clause 7.3.9

Review of design and development do not include evaluation of change effects

Cited by Tyler R Courtney

4 May 2026
ISO 13485:2016 Clause 7.4.1

Criteria for the evaluation and selection of suppliers not established

Cited by Tyler R Courtney

4 May 2026
ISO 13485:2016 Clause 7.5.6

Process for production and service provision not validated

Cited by Tyler R Courtney

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
ISO 13485:2016 Clause 4.1.2Cited across public-safe Form 483 observations1x
ISO 13485:2016 Clause 7.1Cited across public-safe Form 483 observations1x
ISO 13485:2016 Clause 7.3.9Cited across public-safe Form 483 observations1x
ISO 13485:2016 Clause 7.4.1Cited across public-safe Form 483 observations1x
ISO 13485:2016 Clause 7.5.6Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Enterra Medical, Inc.'s 1 Form 483

Recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat